English
简体中文
Total: £ 56.28
2026-03-25 | Pages: 108 | Tables: 109
The global Adsorbed DTP Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape....
2026-03-25 | Pages: 120 | Tables: 118
The global Tetanus Vaccine (Adsorbed) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic land...
2026-03-25 | Pages: 120 | Tables: 126
The global Powdered Glycerin Supplement market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic la...
2026-03-25 | Pages: 125 | Tables: 124
The global Period Cramp Supplement market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landsca...
2026-03-25 | Pages: 138 | Tables: 131
The global Nucleic Acid and Oligonucleotide Drugs market was valued at US$ 13380 million in 2025 and is anticipated to reach US$ 17220 million by 2032, at a CAGR of 3.7% from 2026 to 2032.Nucleic acid drugs, also known as nucleic acid-based therapeut...
2026-03-25 | Pages: 123 | Tables: 127
The global Nucleic Acid and Oligonucleotide Therapeutics market was valued at US$ 13380 million in 2025 and is anticipated to reach US$ 17220 million by 2032, at a CAGR of 3.7% from 2026 to 2032.Nucleic acid drugs, also known as nucleic acid-based th...
2026-03-25 | Pages: 96 | Tables: 91
The global ASO-based Drug market was valued at US$ 4654 million in 2025 and is anticipated to reach US$ 14040 million by 2032, at a CAGR of 17.3% from 2026 to 2032.Antisense Oligonucleotides (ASOs) are a class of nucleic acid drugs designed to target...
2026-03-25 | Pages: 131 | Tables: 123
The global Small Nucleic Acid Therapies market was valued at US$ 13380 million in 2025 and is anticipated to reach US$ 17220 million by 2032, at a CAGR of 3.7% from 2026 to 2032.Small Nucleic Acid Therapies are a class of pharmaceuticals designed to ...
2026-03-25 | Pages: 95 | Tables: 94
The global Antisense Oligonucleotide Therapy for the Nervous System market was valued at US$ 4654 million in 2025 and is anticipated to reach US$ 14040 million by 2032, at a CAGR of 17.3% from 2026 to 2032.Antisense Oligonucleotides (ASOs) are a clas...
2026-03-25 | Pages: 90 | Tables: 98
The global Antisense Oligonucleotides (ASO) Therapy market was valued at US$ 4654 million in 2025 and is anticipated to reach US$ 14040 million by 2032, at a CAGR of 17.3% from 2026 to 2032.Antisense Oligonucleotides (ASOs) are a class of nucleic aci...
2026-03-25 | Pages: 124 | Tables: 138
The global Nucleic Acid-based Therapy market was valued at US$ 13380 million in 2025 and is anticipated to reach US$ 17220 million by 2032, at a CAGR of 3.7% from 2026 to 2032.Nucleic acid drugs, also known as nucleic acid-based therapeutics, are a c...
2026-03-25 | Pages: 130 | Tables: 136
The global Urinary pH Modifiers market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape....
2026-03-25 | Pages: 135 | Tables: 131
The global Pet Cannabidiol market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This...
2026-03-25 | Pages: 120 | Tables: 111
The global Drugs Produced by Fermentation Engineering market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.Fermentation is a process used for cultivating micro-organisms or other or...
2026-03-25 | Pages: 134 | Tables: 133
The global Panax Ginseng Products market was valued at US$ 5000 million in 2025 and is anticipated to reach US$ 7036 million by 2032, at a CAGR of 5.0% from 2026 to 2032.Panax Ginseng Products refer to a diverse range of commodities derived from the ...
